Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,545 | 710 | 97.7% |
| Education | $214.09 | 4 | 2.0% |
| Gift | $30.66 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,581 | 168 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,605 | 155 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,005 | 65 | $0 (2024) |
| Janssen Biotech, Inc. | $898.09 | 59 | $0 (2024) |
| Gilead Sciences, Inc. | $538.19 | 26 | $0 (2023) |
| Celgene Corporation | $520.34 | 35 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $390.03 | 25 | $0 (2024) |
| Daiichi Sankyo Inc. | $318.86 | 19 | $0 (2022) |
| Synergy Pharmaceuticals Inc | $260.14 | 23 | $0 (2018) |
| Braintree Laboratories, Inc. | $247.38 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,634 | 108 | ABBVIE INC. ($539.83) |
| 2023 | $1,754 | 116 | AbbVie Inc. ($379.38) |
| 2022 | $1,940 | 141 | ABBVIE INC. ($449.39) |
| 2021 | $1,575 | 101 | AbbVie Inc. ($354.24) |
| 2020 | $733.54 | 42 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($156.54) |
| 2019 | $1,131 | 75 | AbbVie, Inc. ($233.41) |
| 2018 | $1,286 | 87 | Takeda Pharmaceuticals U.S.A., Inc. ($314.68) |
| 2017 | $736.71 | 47 | AbbVie, Inc. ($213.89) |
All Payment Transactions
717 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $9.02 | General |
| Category: Gastroenterology | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $4.63 | General |
| Category: Immunology | ||||||
| 11/26/2024 | ABBVIE INC. | CREON (Drug), LINZESS, VIBERZI | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: Gastroenterology | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $10.75 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Rare Disease | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $4.37 | General |
| Category: Immunology | ||||||
| 11/15/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $38.50 | General |
| Category: LIVER DISEASE | ||||||
| 11/14/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Immunology | ||||||
| 11/14/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Hematology | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: Immunology | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: VIROLOGY | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $4.43 | General |
| Category: Immunology | ||||||
| 11/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Gastroenterology | ||||||
| 11/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $1.66 | General |
| Category: Gastroenterology | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 967 | 1,119 | $356,501 | $117,586 |
| 2022 | 16 | 882 | 1,018 | $328,547 | $114,149 |
| 2021 | 20 | 865 | 1,035 | $276,937 | $96,088 |
| 2020 | 29 | 1,365 | 1,958 | $379,405 | $120,353 |
All Medicare Procedures & Services
84 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 207 | 302 | $42,280 | $26,120 | 61.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 122 | 125 | $101,875 | $24,172 | 23.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 156 | 156 | $29,166 | $16,765 | 57.5% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2023 | 18 | 18 | $18,540 | $8,891 | 48.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 89 | 90 | $40,500 | $6,144 | 15.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 43 | 44 | $6,820 | $4,127 | 60.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 40 | 61 | $5,185 | $3,500 | 67.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 54 | 54 | $6,627 | $3,382 | 51.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 29 | $5,655 | $3,291 | 58.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 21 | 21 | $4,998 | $3,057 | 61.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 17 | 17 | $9,860 | $2,880 | 29.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 31 | 34 | $23,290 | $2,603 | 11.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 41 | $4,100 | $2,257 | 55.1% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 13 | 13 | $7,540 | $2,206 | 29.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 18 | 19 | $11,020 | $2,169 | 19.7% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 17 | 27 | $5,670 | $2,137 | 37.7% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 29 | 29 | $11,165 | $2,070 | 18.5% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 17 | 17 | $22,100 | $1,806 | 8.2% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 13 | 22 | $110.00 | $9.65 | 8.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 113 | 113 | $92,095 | $22,388 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 173 | 250 | $35,000 | $21,762 | 62.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 142 | 142 | $26,624 | $16,848 | 63.3% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2022 | 18 | 18 | $18,540 | $10,242 | 55.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 104 | 108 | $48,600 | $7,309 | 15.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 35 | 55 | $10,725 | $6,807 | 63.5% |
About Cody Barnett
Cody Barnett is a Gastroenterology healthcare provider based in Mobile, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477642890.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Cody Barnett has received a total of $10,790 in payments from pharmaceutical and medical device companies, with $1,634 received in 2024. These payments were reported across 717 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($10,545).
As a Medicare-enrolled provider, Barnett has provided services to 4,079 Medicare beneficiaries, totaling 5,130 services with total Medicare billing of $448,177. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Mobile, AL
- Active Since 10/12/2006
- Last Updated 10/13/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1477642890
Products in Payments
- TRULANCE (Drug) $985.69
- STELARA (Biological) $938.25
- RINVOQ (Biological) $611.11
- ZEPOSIA (Drug) $507.85
- MAVYRET (Drug) $390.35
- SKYRIZI (Biological) $380.93
- ENTYVIO (Biological) $366.74
- HUMIRA (Biological) $365.16
- XIFAXAN (Drug) $358.01
- Mavyret (Drug) $355.94
- Entyvio (Biological) $334.60
- RELISTOR (Drug) $321.94
- INJECTAFER (Drug) $302.74
- Linzess (Drug) $292.27
- Humira (Biological) $289.32
- Trulance (Drug) $260.14
- LINZESS (Drug) $247.12
- DUPIXENT (Biological) $214.63
- IBSRELA (Drug) $192.35
- OCALIVA (Drug) $157.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Mobile
Jack Dipalma, Md, MD
Gastroenterology — Payments: $982,519
Jorge Herrera, Md, MD
Gastroenterology — Payments: $326,803
Dr. Michael Sanders, Md, MD
Gastroenterology — Payments: $83,879
Dr. Matthew Eves, M.d, M.D
Gastroenterology — Payments: $73,009
Dr. Susan Fleet, Md, MD
Gastroenterology — Payments: $15,558
Reynaldo Rodriguez, Do, DO
Gastroenterology — Payments: $8,450